These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 18439109

  • 21. Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies.
    Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF.
    J Med Genet; 2005 Jul; 42(7):602-3. PubMed ID: 15994883
    [Abstract] [Full Text] [Related]

  • 22. Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.
    Lehrer S, Fodor F, Stock RG, Stone NN, Eng C, Song HK, McGovern M.
    Br J Cancer; 1998 Sep; 78(6):771-3. PubMed ID: 9743298
    [Abstract] [Full Text] [Related]

  • 23. Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
    Walsh T, Mandell JB, Norquist BM, Casadei S, Gulsuner S, Lee MK, King MC.
    JAMA Oncol; 2017 Dec 01; 3(12):1647-1653. PubMed ID: 28727877
    [Abstract] [Full Text] [Related]

  • 24. Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.
    Wolf I, Laitman Y, Rubinek T, Abramovitz L, Novikov I, Beeri R, Kuro-O M, Koeffler HP, Catane R, Freedman LS, Levy-Lahad E, Karlan BY, Friedman E, Kaufman B.
    Oncogene; 2010 Jan 07; 29(1):26-33. PubMed ID: 19802015
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population.
    Lavie O, Narod S, Lejbkowicz F, Dishon S, Goldberg Y, Gemer O, Rennert G.
    Ann Oncol; 2011 Apr 07; 22(4):964-966. PubMed ID: 20924075
    [Abstract] [Full Text] [Related]

  • 27. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S, Jain N, Husain SA, Mandal AK, Ray G, Shahid M, Kant R, Gupta V, Shukla NK, Deo SS, Das BC.
    Breast Cancer Res Treat; 2004 Nov 07; 88(2):177-86. PubMed ID: 15564800
    [Abstract] [Full Text] [Related]

  • 28. Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations.
    Ramus SJ, Fishman A, Pharoah PD, Yarkoni S, Altaras M, Ponder BA.
    Eur J Surg Oncol; 2001 Apr 07; 27(3):278-81. PubMed ID: 11373105
    [Abstract] [Full Text] [Related]

  • 29. Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel.
    Laitman Y, Simeonov M, Herskovitz L, Kushnir A, Shimon-Paluch S, Kaufman B, Zidan J, Friedman E.
    Breast Cancer Res Treat; 2012 Jun 07; 133(3):1153-7. PubMed ID: 22399190
    [Abstract] [Full Text] [Related]

  • 30. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
    Tonin PN.
    Bull Cancer; 2006 Sep 07; 93(9):841-6. PubMed ID: 16980226
    [Abstract] [Full Text] [Related]

  • 31. BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland.
    Perkowska M, BroZek I, Wysocka B, Haraldsson K, Sandberg T, Johansson U, Sellberg G, Borg A, Limon J.
    Hum Mutat; 2003 May 07; 21(5):553-4. PubMed ID: 12673801
    [Abstract] [Full Text] [Related]

  • 32. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
    Roa BB, Boyd AA, Volcik K, Richards CS.
    Nat Genet; 1996 Oct 07; 14(2):185-7. PubMed ID: 8841191
    [Abstract] [Full Text] [Related]

  • 33. Five Italian Families with Two Mutations in BRCA Genes.
    Vietri MT, Caliendo G, D'Elia G, Resse M, Casamassimi A, Minucci PB, Dello Ioio C, Cioffi M, Molinari AM.
    Genes (Basel); 2020 Dec 03; 11(12):. PubMed ID: 33287145
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma.
    Biron-Shental T, Drucker L, Altaras M, Bernheim J, Fishman A.
    Eur J Surg Oncol; 2006 Dec 03; 32(10):1097-100. PubMed ID: 16650962
    [Abstract] [Full Text] [Related]

  • 36. A family with three germline mutations in BRCA1 and BRCA2.
    Liede A, Metcalfe K, Offit K, Brown K, Miller S, Narod SA, Moslehi R.
    Clin Genet; 1998 Sep 03; 54(3):215-8. PubMed ID: 9788724
    [Abstract] [Full Text] [Related]

  • 37. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
    Holter S, Borgida A, Dodd A, Grant R, Semotiuk K, Hedley D, Dhani N, Narod S, Akbari M, Moore M, Gallinger S.
    J Clin Oncol; 2015 Oct 01; 33(28):3124-9. PubMed ID: 25940717
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.